{"id":"NCT03181932","sponsor":"Savara Inc.","briefTitle":"AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis","officialTitle":"A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-09-20","primaryCompletion":"2020-07-28","completion":"2021-01-15","firstPosted":"2017-06-09","resultsPosted":"2021-11-05","lastUpdate":"2022-12-16"},"enrollment":188,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["MRSA","Cystic Fibrosis"],"interventions":[{"type":"DRUG","name":"Vancomycin inhalation powder","otherNames":["AeroVanc"]},{"type":"DRUG","name":"Placebo inhalation powder","otherNames":[]},{"type":"DRUG","name":"Vancomycin inhalation powder","otherNames":["AeroVanc"]}],"arms":[{"label":"Double-blind vancomycin inhalation powder","type":"EXPERIMENTAL"},{"label":"Double-blind placebo inhalation powder","type":"PLACEBO_COMPARATOR"},{"label":"Open-label vancomycin inhalation powder","type":"EXPERIMENTAL"}],"summary":"This is a multi-center, randomized phase III study to evaluate the clinical effectiveness of AeroVanc in persistent methicillin-resistant Staphylococcus aureus (MRSA) infection in patients with cystic fibrosis (CF).","primaryOutcome":{"measure":"Absolute Change From Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted","timeFrame":"Baseline and Week 4, 12 and 20","effectByArm":[{"arm":"Double-blind Vancomycin Inhalation Powder","deltaMin":2.39,"sd":8.078},{"arm":"Double-blind Placebo Inhalation Powder","deltaMin":1.18,"sd":8.581}],"pValues":[{"comp":"OG000 vs OG001","p":"0.325"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":71,"countries":["United States","Canada"]},"refs":{"pmids":["36511181"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":90},"commonTop":["Infective pulmonary exacerbation of cystic fibrosis","Cough","Headache","Oropharyngeal pain","Pyrexia"]}}